Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000616·OptimizeRx Corp
Schedule 13G ownership disclosure
OptimizeRx Corp
Common Stock · CUSIP: 68401U204
Event date: 2025-03-31
- Filing-level shares
- 921,848
- Percent of class
- 4.98%
- The Vanguard Group
Shares: 921,848 · Class: 4.98%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000616
- Form type
- SCHEDULE 13G/A
- Filer
- OptimizeRx Corp
- CIK
- CIK 1448431
- Filed
- Apr 30, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership